1
/
of
0
FDA Drug/Biologics Approval BLA 761034 S-019, ATEZOLIZUMAB
FDA Drug/Biologics Approval BLA 761034 S-019, ATEZOLIZUMAB
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
BLA 761034 S-019
Company: GENENTECH INC
Drug Name: TECENTRIQ
Active Ingredients: ATEZOLIZUMAB
Strength: 1200MG/20ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 05/18/2016
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: GENENTECH INC
Drug Name: TECENTRIQ
Active Ingredients: ATEZOLIZUMAB
Strength: 1200MG/20ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 05/18/2016
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details